Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Cranberry Proanthocyanidins, specifically A-type PACs, are potent polyphenolic compounds renowned for their unique ability to prevent bacterial adhesion to cell surfaces. This mechanism is crucial for significantly reducing the frequency of urinary tract infections by blocking uropathogenic E. coli.
Reported Benefits (Provisional)
Origin & History
Proanthocyanidins (PACs) are potent polyphenolic antioxidants derived primarily from the skins and juice concentrates of cranberries (Vaccinium macrocarpon), a fruit native to North America. Known for their distinctive A-type structure, PACs play a critical role in preventing bacterial adhesion in the urinary tract. These bioactive compounds offer multidimensional benefits, supporting urinary tract health, skin elasticity, and cardiovascular function.
Research Narrative (Provisional)
Extensive scientific research, including numerous clinical trials and meta-analyses, confirms the efficacy of A-type Proanthocyanidins (PACs) from cranberries in preventing bacterial adhesion in the urinary tract. Studies also highlight their potent antioxidant, anti-inflammatory, and cardiovascular benefits. These findings solidify PACs as a cornerstone of natural urinary and immune health solutions.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Dietary Fiber: Supports digestive health and regularity. - Vitamin C: Supports immunity, collagen formation, and reduces oxidative stress. - A-Type Proanthocyanidins (PACs): Uniquely inhibit E. coli adhesion in the urinary tract. - Polyphenols: Deliver potent antioxidant and anti-inflammatory effects. - Flavonoids: Promote vascular integrity and improve circulation.
Reported Mechanism (Provisional)
The distinct A-type PACs from cranberries, primarily epicatechin oligomers, uniquely inhibit bacterial adhesion to host cells. They specifically block the P-fimbriae of uropathogenic E. coli from binding to uroepithelial cells, disrupting the initial step of infection. This anti-adhesion effect also extends to Helicobacter pylori in the stomach and various oral bacteria, preventing biofilm formation.
Clinical Narrative (Provisional)
Extensive clinical research, including numerous randomized controlled trials and meta-analyses involving thousands of participants, consistently demonstrates the efficacy of cranberry A-type PACs. Studies confirm their significant role in reducing the recurrence of urinary tract infections, particularly in women. Beyond UTIs, research also supports their potent antioxidant and anti-inflammatory properties, contributing to improved cardiovascular health by reducing LDL oxidation and enhancing endothelial function.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.